Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-02-11 Sale | 2022-02-14 4:19 pm | X4 Pharmaceuticals Inc | XFOR | Cadavid Diego Chief Medical Officer | 928 | $0 | $0 | 7,107 (Direct) | View |
| 2020-07-01 Sale | 2020-07-02 4:19 pm | Fulcrum Therapeutics Inc. | FULC | Cadavid Diego SVP Clinical Development | 1,071 | $18.3 | $19,599 | 65,714 (Direct) | View |
| 2020-06-25 Sale | 2020-06-26 4:17 pm | Fulcrum Therapeutics Inc. | FULC | Cadavid Diego SVP Clinical Development | 1,459 | $22 | $32,098 | 79,062 (Direct) | View |
| 2020-06-10 Sale | 2020-06-12 5:10 pm | Fulcrum Therapeutics Inc. | FULC | Cadavid Diego SVP Clinical Development | 401 | $22 | $8,822 | 80,521 (Direct) | View |
| 2020-06-04 Sale | 2020-06-08 4:17 pm | Fulcrum Therapeutics Inc. | FULC | Cadavid Diego SVP Clinical Development | 677 | $20.14 | $13,632 | 95,510 (Direct) | View |
| 2020-06-02 Sale | 2020-06-04 4:16 pm | Fulcrum Therapeutics Inc. | FULC | Cadavid Diego SVP Clinical Development | 383 | $20.16 | $7,720 | 96,751 (Direct) | View |
| 2020-05-28 Sale | 2020-06-01 4:16 pm | Fulcrum Therapeutics Inc. | FULC | Cadavid Diego SVP Clinical Development | 800 | $20.01 | $16,007 | 97,379 (Direct) | View |
| 2020-05-12 Sale | 2020-05-12 4:15 pm | Fulcrum Therapeutics Inc. | FULC | Cadavid Diego SVP Clinical Development | 1,860 | $18 | $33,480 | 82,782 (Direct) | View |
| 2020-03-02 Sale | 2020-03-02 6:42 pm | Fulcrum Therapeutics Inc. | FULC | Cadavid Diego SVP Clinical Development | 2,143 | $17.38 | $37,255 | 66,785 (Direct) | View |
| 2020-02-03 Sale | 2020-02-05 4:31 pm | Fulcrum Therapeutics Inc. | FULC | Cadavid Diego SVP Clinical Development | 2,143 | $17.33 | $37,142 | 68,928 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-03-01 Option Award | 2022-03-01 4:08 pm | N/A N/A | X4 Pharmaceuticals Inc | XFOR | Cadavid Diego Chief Medical Officer | 97,000 | $0 | 104,107 (Direct) | View |
| 2021-03-24 Option Award | 2021-03-25 4:56 pm | N/A N/A | X4 Pharmaceuticals Inc | XFOR | Cadavid Diego Chief Medical Officer | 8,035 | $0 | 8,035 (Direct) | View |
| 2020-12-31 Option Award | 2021-01-06 08:23 am | N/A 2030-12-31 | X4 Pharmaceuticals Inc | XFOR | Cadavid Diego Chief Medical Officer | 121,500 | $6.43 | 121,500 (Direct) | View |
| 2020-06-25 Exercise | 2020-06-26 4:17 pm | N/A 2028-07-10 | Fulcrum Therapeutics Inc. | FULC | Cadavid Diego SVP Clinical Development | 1,459 | $0 | 79,062 (Direct) | View |
| 2020-06-25 Exercise | 2020-06-26 4:17 pm | N/A N/A | Fulcrum Therapeutics Inc. | FULC | Cadavid Diego SVP Clinical Development | 1,459 | $4.83 | 79,062 (Direct) | View |
| 2020-06-10 Exercise | 2020-06-12 5:10 pm | N/A 2028-07-10 | Fulcrum Therapeutics Inc. | FULC | Cadavid Diego SVP Clinical Development | 401 | $0 | 80,521 (Direct) | View |
| 2020-06-10 Exercise | 2020-06-12 5:10 pm | N/A N/A | Fulcrum Therapeutics Inc. | FULC | Cadavid Diego SVP Clinical Development | 401 | $4.83 | 80,521 (Direct) | View |
| 2020-06-04 Exercise | 2020-06-08 4:17 pm | N/A 2028-07-10 | Fulcrum Therapeutics Inc. | FULC | Cadavid Diego SVP Clinical Development | 677 | $0 | 95,510 (Direct) | View |
| 2020-06-04 Exercise | 2020-06-08 4:17 pm | N/A N/A | Fulcrum Therapeutics Inc. | FULC | Cadavid Diego SVP Clinical Development | 677 | $4.83 | 95,510 (Direct) | View |
| 2020-06-02 Exercise | 2020-06-04 4:16 pm | N/A 2028-07-10 | Fulcrum Therapeutics Inc. | FULC | Cadavid Diego SVP Clinical Development | 383 | $0 | 96,751 (Direct) | View |
| 2020-06-02 Exercise | 2020-06-04 4:16 pm | N/A N/A | Fulcrum Therapeutics Inc. | FULC | Cadavid Diego SVP Clinical Development | 383 | $4.83 | 96,751 (Direct) | View |
| 2020-05-28 Exercise | 2020-06-01 4:16 pm | N/A 2028-07-10 | Fulcrum Therapeutics Inc. | FULC | Cadavid Diego SVP Clinical Development | 800 | $0 | 97,379 (Direct) | View |
| 2020-05-28 Exercise | 2020-06-01 4:16 pm | N/A N/A | Fulcrum Therapeutics Inc. | FULC | Cadavid Diego SVP Clinical Development | 800 | $4.83 | 97,379 (Direct) | View |
| 2020-05-12 Exercise | 2020-05-12 4:15 pm | N/A 2028-07-10 | Fulcrum Therapeutics Inc. | FULC | Cadavid Diego SVP Clinical Development | 1,860 | $0 | 82,782 (Direct) | View |
| 2020-05-12 Exercise | 2020-05-12 4:15 pm | N/A N/A | Fulcrum Therapeutics Inc. | FULC | Cadavid Diego SVP Clinical Development | 1,860 | $4.83 | 82,782 (Direct) | View |
| 2020-01-23 Option Award | 2020-01-27 4:30 pm | N/A 2030-01-22 | Fulcrum Therapeutics Inc. | FULC | Cadavid Diego SVP Clinical Development | 55,440 | $0 | 55,440 (Direct) | View |
| 2019-07-18 Option Award | 2019-07-18 5:26 pm | N/A 2029-07-17 | Fulcrum Therapeutics Inc. | FULC | Cadavid Diego See Remarks | 12,784 | $0 | 12,784 (Direct) | View |
Ownership | 2019-07-17 7:39 pm | N/A N/A | Fulcrum Therapeutics Inc. | FULC | Cadavid Diego See Remarks | 0 | $0 | 169,856 (Direct) | View |